Barinthus Biotherapeutics plc share price logo

Barinthus Biotherapeutics plc

NASDAQ: BRNS

Small Cap

$0.63

-0.02

(-2.49%)

Live

as on

Barinthus Biotherapeutics plc Stock Performance

as on May 5, 2026 at 1:08 am IST

  • $0.63
    $0.63

  • 52 Week's Low

    52 Week's High

    $0.51
    $2.92
    downward going graph

    18.73%

    Downside

    363.49%

    Upside

    downward going graph

Barinthus Biotherapeutics plc share price movements today

Previous Close
$0.65
Open
$0.63
Volume
94.6K
Day's Low - High
$0.63 - $0.63
52 Week Low - High
$0.51 - $2.92

Barinthus Biotherapeutics plc Historical Returns

1 Month Return
+ 8.45 %
3 Month Return
-7.04 %
1 Year Return
-28.65 %
3 Year Return
0 %
5 Year Return
0 %

Barinthus Biotherapeutics plc Stock Fundamentals & Key Indicators

Check Barinthus Biotherapeutics plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$26.6M

EPS (TTM)

-1.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-55.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-65.02%

Barinthus Biotherapeutics plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Barinthus Biotherapeutics plc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Barinthus Biotherapeutics plc image
Barinthus Biotherapeutics plc
BUY$26.6MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.5B125.06%74.5912.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$107.8B97.31%27.7132.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA118.975.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.5B44.57%17.1229.65%

Stock Returns calculator for Barinthus Biotherapeutics plc Stock including INR - Dollar returns

The Barinthus Biotherapeutics plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Barinthus Biotherapeutics plc investment value today

Current value as on today

₹78,078

Returns

-₹21,922

(-21.92%)

Returns from Barinthus Biotherapeutics plc Stock

-₹30,769 (-30.77%)

Dollar Impact

₹8,847 (+8.85%)

Analyst Recommendation on Barinthus Biotherapeutics plc Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Barinthus Biotherapeutics plc. Average target price of $5.5

Barinthus Biotherapeutics plc Share Price Target

Get share price movements and forecasts by analysts on Barinthus Biotherapeutics plc.

What analysts predicted

88.55%UPSIDE

Target Price

$5.5

Current Price

$0.63

Analyzed by

12 Analysts

Target

$5.50

Barinthus Biotherapeutics plc target price $5.5, a slight upside of 88.55% compared to current price of $0.63. According to 12 analysts rating.

Barinthus Biotherapeutics plc Stock’s Investor Sentiment and Interest

Search interest for Barinthus Biotherapeutics plc Stock has increased by 143% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:143% versus previous 30 day period

Barinthus Biotherapeutics plc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
5
-
-
14
-9
-
-
-
-
Gross Profit
3
-1
-1
14
-12
-2
-2
-
0
Operating Income
-19
-16
-18
-9
-23
-20
-23
-15
4
EBITDA
-16
-14
-15
-6
-19
-17
-19
-13
-8
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
1
2
2
0
0
Income Before Tax
-18
-15
-16
-8
-20
-19
-21
-14
-13
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-17
-15
-16
-8
-20
-19
-21
-14
-11
Net Profit Margin
-322.09%
0.00%
0.00%
-54.21%
223.92%
0.00%
0.00%
0.00%
0.00%

Barinthus Biotherapeutics plc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
4
0
44
0
14
-
Gross Profit
-22
-9
0
44
0
14
-5
Operating Income
-25
-20
-45
-4
-83
-67
-54
EBITDA
-22
-16
-47
5
-71
-55
-48
Interest Expense
0
3
2
0
0
0
0
Depreciation
-
0
0
4
5
5
5
Income Before Tax
-22
-17
-51
0
-76
-61
-68
Income Tax Expense
-2
0
0
-4
-3
0
0
Net Income
-20
-17
-50
5
-73
-61
-66
Net Profit Margin
-302.84%
-367.27%
-18979.48%
11.95%
-9145.51%
-408.00%
0.00%

Barinthus Biotherapeutics plc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-15
-16
-8
-20
-19
-21
-14
-11
-5
Operating Cash Flow
-11
-12
-18
13
-14
-18
-10
-4
-3
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
0
0
0
0
-
-
Change in Cash
-12
-12
-11
6
-11
-12
-12
-3
-4

Barinthus Biotherapeutics plc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-51
5
-73
-61
-66
Operating Cash Flow
-11
-32
-14
-50
-28
-47
Investing Cash Flow
0
-12
-5
-5
0
0
Financing Cash Flow
41
222
0
1
2
0
Change in Cash
31
170
-19
-52
-29
-40

Global Institutional Holdings in Barinthus Biotherapeutics plc

Funds
Holdings
The Johns Hopkins University
0.3%
DC Funds, LP
1.57%
Rhumbline Advisers
0.03%
HighTower Advisors, LLC
0.09%
Morgan Stanley - Brokerage Accounts
0.01%
See all

Insights on Barinthus Biotherapeutics plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -21.12M → -5.53M (in $), with an average increase of 59.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, BARINTHUS BIOTHERAPEUTICS PLC has experienced a drawdown of -72.4%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 65.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 15.8% return, outperforming this stock by 44.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, BRNS stock has moved down by -43.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 14.96M → -9.17M (in $), with an average decrease of 161.3% per quarter

About Barinthus Biotherapeutics plc

Barinthus Biotherapeutics plc, together with its subsidiaries, engages in the research, development, and commercialization of immunotherapies and vaccines in the United States and the United Kingdom. The company develops VTP-1000, an antigen-specific immune tolerance candidate, which is in Phase I clinical trial to restore immune non-responsiveness to gluten in patients with celiac disease; and VTP-300, an immunotherapy, which is in Phase II clinical trial for the treatment of chronic hepatitis B virus infection. It has a license agreement with Oxford University Innovation for the development and commercialization of products with thermo-responsive adjuvant scaffolds; and U.S. National Institutes of Health for the evaluation of synthetic and polymer-based vaccine technology to prevent infectious disease and treat cancer in animal models. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is based in Germantown, Maryland.
OrganisationBarinthus Biotherapeutics plc
Headquarters20400 Century Boulevard, Germantown, MD, United States, 20874
IndustryBiotechnology
CEOMr. William James Enright MBA
E-voting on sharesClick here to vote

Key Management of Barinthus Biotherapeutics plc

Name

Title

Mr. William James Enright MBA

CEO, Director, Secretary & Principal Financial Officer

Dr. Leon Hooftman M.D.

Chief Medical Officer

FAQs

What is Barinthus Biotherapeutics plc share price today?

Barinthus Biotherapeutics plc share price today is $0.63 as on . Barinthus Biotherapeutics plc share today touched a day high of $0.63 and a low of $0.63.

What is the 52 week high and 52 week low for Barinthus Biotherapeutics plc share?

Barinthus Biotherapeutics plc share touched a 52 week high of $2.92 on and a 52 week low of $0.51 on . Barinthus Biotherapeutics plc stock price today i.e. is trending at $0.63,which is 78.42% down from its 52 week high and 23.05% up from its 52 week low.

What is Barinthus Biotherapeutics plc's market capitalisation today?

Barinthus Biotherapeutics plc market capitalisation is $0.00T as on .

How to invest in Barinthus Biotherapeutics plc Stock (BRNS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Barinthus Biotherapeutics plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Barinthus Biotherapeutics plc Shares that will get you 2.3810 shares as per Barinthus Biotherapeutics plc share price of $0.63 per share as on May 4, 2026 at 7:38 pm IST.

What is the minimum amount required to buy Barinthus Biotherapeutics plc Stock (BRNS) from India?

Indian investors can start investing in Barinthus Biotherapeutics plc (BRNS) shares with as little as ₹95.067 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in Barinthus Biotherapeutics plc stock (as per the Rupee-Dollar exchange rate as on ). Based on Barinthus Biotherapeutics plc share’s latest price of $0.63 as on May 4, 2026 at 7:38 pm IST, you will get 15.8730 shares of Barinthus Biotherapeutics plc. Learn more about fractional shares .